Laser Scanning Cytometer
激光扫描细胞仪
基本信息
- 批准号:7595975
- 负责人:
- 金额:$ 39.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-12-22 至 2009-12-21
- 项目状态:已结题
- 来源:
- 关键词:AreaAutoimmune DiseasesCancer BiologyCancer CenterCellsCommunicable DiseasesCultured CellsDataDevelopmentEnsureFacultyFlow CytometryFluorescenceFundingHousingHybridsImageImage AnalysisImmunologyInstitutionLabelLaboratoriesLasersLifeMicroscopeMicroscopicMicroscopyMonitorOperative Surgical ProceduresRequest for ApplicationsResearch PersonnelResearch Project GrantsSamplingScanningScienceSignal TransductionSlideSpecimenStagingSupervisionSurfaceTechnologyTimeTissuesTranslational ResearchTubecell fixingdetectorexperienceinstrumentlensmeetingsmembernew technologyphotomultiplierpublic health relevance
项目摘要
DESCRIPTION (provided by applicant): We are requesting funds for a Compucyte iCys Laser Scanning Cytometer (LSC). The LSC is a relatively recently developed instrument that joins many of the advantages of traditional microscopy and flow cytometry, and significantly extends the limits of single cell analyses. Rather than randomly imaging an entire field like a microscope does, it selects, images and analyzes cells that meet certain adjustable criteria (such as size or fluorescence). Unlike conventional flow cytometry, the LSC is usually used to analyze cells fixed to horizontal surface, such as cultured cells on slides or in a variety of culture vessels. Live cells can be imaged and cytometrically analyzed for fluorescent signals, and a variety of types of fixed specimens can also be studied in this way. The instrument uses an automated nanostep X-Y stage to move samples through the objective lens, applying up to three different lasers to excite fluorescent emissions and quantitating these using an array of four photomultiplier tube (PMT) detectors. Thus, the LSC is essentially a powerful hybrid technology that combines imaging and cytometric analysis in a single platform. Importantly, with the LSC image becomes a parameter, and detailed microscopic pictures are stored and referenced directly to cytometric data. A highly appealing feature of the instrument that we plan to use extensively is its ability to gather quantitative fluorescence data from microscopic areas of fluorescently labeled tissue sections, and to display and analyze such data in a manner that is comparable in many cases to true cytometric data such as one obtains with traditional flow cytometry. We plan to house and operate the iCys LSC in our well established central Flow Cytometry Core Laboratory, where there will be ample expertise and oversight to ensure that the instrument is used to its full capacity. The Core Laboratory has an experienced senior faculty member (Dr. Steven Porcelli) as its supervisor, and employs three full time faculty level associates to direct operations and provide technical supervision. There is also a range of internal consultants with expertise in areas of major relevance to the development of applications that will use the LSC. The Core Laboratory has a well developed and carefully monitored financial plan, and receives substantial institutional support from the institution and from our NCI-funded Cancer Center to ensure its efficient and stable operation. By incorporating the iCys LSC into this core laboratory, a large body of investigators pursuing many diverse NIH-funded basic and translational research projects will gain convenient and affordable access to this important new technology. Public Health Relevance: This application requests funding that will allow our Flow Cytometry Core Laboratory to acquire a new analytical instrument called the Compucyte iCys Laser Scanning Cytometer. This instrument will provide many researchers at our institution with a powerful new way to analyze cells and tissues. The studies that will be done with this instrument will advance our understanding of a wide spectrum of areas with high relevance to biomedical science, including cancer biology, immunology, autoimmune diseases and infectious diseases.
描述(由申请人提供):我们正在申请资金购买Compucyte iCys激光扫描细胞仪(LSC)。LSC是一种相对较新开发的仪器,结合了传统显微镜和流式细胞术的许多优点,并显着扩展了单细胞分析的限制。它不像显微镜那样随机地对整个视野进行成像,而是选择、成像和分析满足某些可调节标准(如大小或荧光)的细胞。与传统的流式细胞术不同,LSC通常用于分析固定在水平表面上的细胞,例如载玻片上或各种培养容器中的培养细胞。活细胞可以成像和细胞计数分析荧光信号,各种类型的固定标本也可以通过这种方式进行研究。该仪器使用自动纳米级X-Y载物台将样品移动通过物镜透镜,应用多达三种不同的激光激发荧光发射,并使用四个光电倍增管(PMT)检测器阵列对这些进行定量。因此,LSC本质上是一种强大的混合技术,将成像和细胞计数分析结合在一个平台上。重要的是,LSC图像成为一个参数,详细的显微照片被存储并直接引用到细胞计数数据。我们计划广泛使用的仪器的一个非常有吸引力的功能是它能够从荧光标记的组织切片的微观区域收集定量荧光数据,并以在许多情况下与真正的细胞计数数据(如用传统流式细胞术获得的数据)相当的方式显示和分析这些数据。我们计划在我们完善的中央流式细胞术核心实验室中安置和操作iCys LSC,在那里将有充足的专业知识和监督,以确保仪器充分利用其能力。核心实验室有一位经验丰富的高级教师(Steven Porcelli博士)作为其主管,并雇用了三名全职教师级别的同事来指导操作和提供技术监督。还有一系列内部顾问,他们在与使用LSC的应用程序开发相关的领域具有专业知识。核心实验室有一个完善的和仔细监测的财务计划,并从该机构和我们的NCI资助的癌症中心获得大量的机构支持,以确保其有效和稳定的运作。通过将iCys LSC纳入这个核心实验室,大量从事NIH资助的基础和转化研究项目的研究人员将方便且负担得起地获得这项重要的新技术。公共卫生相关性:该申请要求提供资金,使我们的流式细胞术核心实验室能够购买一种名为Compucyte iCys激光扫描细胞仪的新分析仪器。该仪器将为我们机构的许多研究人员提供一种分析细胞和组织的强大新方法。将使用该仪器进行的研究将促进我们对与生物医学科学高度相关的广泛领域的理解,包括癌症生物学,免疫学,自身免疫性疾病和传染病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven A Porcelli其他文献
Steven A Porcelli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven A Porcelli', 18)}}的其他基金
Bigfoot Multispectral High Speed Fluorescence Activated Cell Sorter
Bigfoot 多光谱高速荧光激活细胞分选仪
- 批准号:
10414835 - 财政年份:2022
- 资助金额:
$ 39.84万 - 项目类别:
"Determinants of T Cell Immunity to Tuberculosis Vaccines"
“T细胞对结核疫苗免疫的决定因素”
- 批准号:
8871648 - 财政年份:2015
- 资助金额:
$ 39.84万 - 项目类别:
Construction of safe and effective live tuberculosis vaccines
安全有效的结核活疫苗的构建
- 批准号:
8230473 - 财政年份:2011
- 资助金额:
$ 39.84万 - 项目类别:
Defining the Correlates of Bactericidal Immunity in Tuberculosis
定义结核病杀菌免疫的相关性
- 批准号:
8031491 - 财政年份:2011
- 资助金额:
$ 39.84万 - 项目类别:
Construction of safe and effective live tuberculosis vaccines
安全有效的结核活疫苗的构建
- 批准号:
8626351 - 财政年份:2011
- 资助金额:
$ 39.84万 - 项目类别:
"Determinants of T Cell Immunity to Tuberculosis Vaccines"
“T细胞对结核疫苗免疫的决定因素”
- 批准号:
8049854 - 财政年份:2011
- 资助金额:
$ 39.84万 - 项目类别:
Construction of safe and effective live tuberculosis vaccines
安全有效的结核活疫苗的构建
- 批准号:
8083413 - 财政年份:2011
- 资助金额:
$ 39.84万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 39.84万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 39.84万 - 项目类别:
Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 39.84万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 39.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 39.84万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 39.84万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 39.84万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 39.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 39.84万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 39.84万 - 项目类别: